Armata Pharmaceuticals, Inc. Common Stock (ARMP)
Cost of Revenue
$591.00K
Quarterly · Period ending: · USD
ARMP Cost of Revenue
Latest reported$591.00Kperiod ending
Latest reported$591.00Kperiod ending
ARMP Quarterly Cost of Revenue ($0.00 → $591.00K)
Quarterly cost of revenue
High-resolution chart · PNG
ARMP cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| -400,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |